Leading international law firm Clifford Chance has advised SeaTown Private Capital Master Fund, the private equity fund managed by Singapore-based investment manager, SeaTown Holdings International Pte. Ltd. on its investment into Foundation Healthcare Holdings Pte. Ltd. (FHH). FHH is a ground-up, purpose-built and technology-enabled healthcare platform headquartered in Singapore and has been established with over 50 specialists spanning 13 medical specialties and an estimated pro-forma revenue of over S$130 million.
Partner Valerie Kong led the deal, with support from senior associate Ivan Chan, and associates Victor Leung and John Wu. The core deal team was supported by various teams across the Clifford Chance network, including on financing, antitrust, regulatory and capital markets aspects.
Valerie said, “We are immensely proud to support SeaTown on its investment into FHH. Singapore’s robust healthcare industry continues to be a key sector for investments by financial investors. We wish SeaTown and the FHH management team every success with their partnership.”
Clifford Chance has an extensive portfolio consisting of transactions in healthcare within Asia Pacific. It most recently advised CVC on its acquisition of Xi’an Yikang Pharmacy, Sipai Health Technology’s Hong Kong IPO and Listing, and Prenetics on its acquisition of majority stake in ACT Genomics.
